Lipella Pharmaceuticals Inc. (Nasdaq: LIPO), a clinical-stage biotechnology company focused on developing innovative therapies for serious diseases with unmet medical needs, today announced that U.S.
edatanetworks Inc. announced today the approval of patent 18/385,505 from the United States Patent and Trademark Office (USPTO). This patent further strengthens edatanetworks' intellectual property ...
Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that ...